- Member, SickKids Board of Trustees
Cheryl Reicin is a partner with the law firm of Torys LLP and chair of Torys’ Life Science Practice, a cross-border group in both Canada and the U.S. Reicin is one of the leading practitioners in the life science area globally, having represented more than 350 companies. Prior to joining Torys, Reicin led the 85 attorney life science group of a US law firm.
Reicin’s practice focuses on biotechnology, medical device, health information and other technology-based companies, and representation of private equity/venture capital funds and investment banks that fund such companies. She also represents academic medical centers and universities. She has the sole distinction of being ranked in international and national rankings as a leading lawyer in life sciences in both the US and Canada and has received numerous recognitions and awards, including, among others, LMG Life Science’s Finance & Transactional Lawyer of the Year, Best Lawyers in Canada – Life Science Lawyer of the Year and Canada’s Top 25 Women of Influence and has been inducted into Canada's 100 Most Powerful Women Hall of Fame.
Reicin represents a spectrum of life science companies globally, with emphasis in U.S., Canada and Israel, from start-ups to large public companies, as well as investors and investment banks. She advises companies in private and public financings; mergers and acquisitions; joint ventures, licensing transactions and other strategic partnerships; and corporate and strategic structuring, throughout the world.
Reicin is a graduate of Barnard College, Columbia University and the Harvard Law School. She is involved in numerous charitable endeavors, including, among others, serving as a member of the Board of Directors of SickKids Foundation, the chair and Founder of Genesis UJA, a member of the business advisory board of the Lauder family’s Institute for the Study of Aging, and a steering committee member of W*I*T*H (Women Innovating Together in Healthcare).
Reicin joined the SickKids Board of Trustees in 2012.